AAAAAA

   
Results: 1-25 | 26-50 | 51-57
Results: 1-25/57
A comparison of radical retropubic with perineal prostatectomy for localized prostate cancer within the Uniformed Services Urology Research Group
Authors: Lance, RS Freidrichs, PA Kane, C Powell, CR Pulos, E Moul, JW McLeod, DG Cornum, RL Thrasher, JB
Citation: Rs. Lance et al., A comparison of radical retropubic with perineal prostatectomy for localized prostate cancer within the Uniformed Services Urology Research Group, BJU INT, 87(1), 2001, pp. 61-65
Introduction to Department of Defense Center for Prostate Disease ResearchMulticenter National Prostate Cancer Database, and analysis of changes in the PSA-era
Authors: Sun, L Gancarczyk, K Paquette, EL McLeod, DG Kane, C Kusuda, L Lance, R Herring, J Foley, J Baldwin, D Bishoff, JT Soderdahl, D Wu, HY Xu, L Moul, JW
Citation: L. Sun et al., Introduction to Department of Defense Center for Prostate Disease ResearchMulticenter National Prostate Cancer Database, and analysis of changes in the PSA-era, UROL ONCOL, 6(5), 2001, pp. 203-209
A novel human cancer culture model for the study of prostate cancer
Authors: Yasunaga, Y Nakamura, K Ko, DJ Srivstava, S Moul, JW Sesterhenn, IA McLeod, DG Rhim, JS
Citation: Y. Yasunaga et al., A novel human cancer culture model for the study of prostate cancer, ONCOGENE, 20(55), 2001, pp. 8036-8041
Combined-modality staging for localized adenocarcinoma of the prostate - The D'Amico article reviewed
Authors: Moul, JW
Citation: Jw. Moul, Combined-modality staging for localized adenocarcinoma of the prostate - The D'Amico article reviewed, ONCOLOGY-NY, 15(8), 2001, pp. 1060-1062
The role of imaging studies and molecular markers for selecting candidatesfor radical prostatectomy
Authors: Moul, JW Kane, CJ Malkowicz, SB
Citation: Jw. Moul et al., The role of imaging studies and molecular markers for selecting candidatesfor radical prostatectomy, UROL CLIN N, 28(3), 2001, pp. 459
Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy
Authors: Amling, CL Kane, CJ Riffenburgh, RH Ward, JF Roberts, JL Lance, RS Friedrichs, PA Moul, JW
Citation: Cl. Amling et al., Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy, UROLOGY, 58(5), 2001, pp. 723-728
Se of serum creatinine to predict pathologic stage and recurrence among radical prostatectomy patients
Authors: Merseburger, AS Connelly, RR Sun, L Richter, E Moul, JW
Citation: As. Merseburger et al., Se of serum creatinine to predict pathologic stage and recurrence among radical prostatectomy patients, UROLOGY, 58(5), 2001, pp. 729-734
Prostate-specific antigen-enhanced testing and risk stratification for chemoprevention trials
Authors: Moul, JW
Citation: Jw. Moul, Prostate-specific antigen-enhanced testing and risk stratification for chemoprevention trials, UROLOGY, 57(4A), 2001, pp. 174-177
Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the center for prostate disease research and cancer of the prostate strategic urologic research endeavor databases
Authors: Moul, JW Connelly, RR Lubeck, DP Bauer, JJ Sun, L Flanders, SC Grossfeld, GD Carroll, PR
Citation: Jw. Moul et al., Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the center for prostate disease research and cancer of the prostate strategic urologic research endeavor databases, J UROL, 166(4), 2001, pp. 1322-1327
Prostate specific antigen kinetics at tumor recurrence after radical prostatectomy do not suggest a worse disease prognosis in black men
Authors: Bissonette, EA Fulmer, BR Petroni, GR Moul, JW Theodorescu, D
Citation: Ea. Bissonette et al., Prostate specific antigen kinetics at tumor recurrence after radical prostatectomy do not suggest a worse disease prognosis in black men, J UROL, 166(4), 2001, pp. 1328-1331
Natural history of lower urinary tract symptoms in black American men: Relationships with aging, prostate size, flow rate and bothersomeness - Comment
Authors: Moul, JW
Citation: Jw. Moul, Natural history of lower urinary tract symptoms in black American men: Relationships with aging, prostate size, flow rate and bothersomeness - Comment, J UROL, 165(5), 2001, pp. 1525-1525
The development of erectile dysfunction in men treated for prostate cancer
Authors: Siegel, T Moul, JW Spevak, M Alvord, WG Costabile, RA
Citation: T. Siegel et al., The development of erectile dysfunction in men treated for prostate cancer, J UROL, 165(2), 2001, pp. 430-435
Changing face and different countenances of prostate cancer: Racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era
Authors: Jani, AB Vaida, F Hanks, G Asbell, S Sartor, O Moul, JW Roach, M Brachman, D Kalokhe, U Muller-Runkel, R Ray, P Ignacio, L Awan, A Weichselbaum, RR Vijayakumar, S
Citation: Ab. Jani et al., Changing face and different countenances of prostate cancer: Racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era, INT J CANC, 96(6), 2001, pp. 363-371
Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes
Authors: Xu, LL Su, YP Labiche, R Segawa, T Shanmugam, N McLeod, DG Moul, JW Srivastava, S
Citation: Ll. Xu et al., Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes, INT J CANC, 92(3), 2001, pp. 322-328
Improvements in pathologic staging for African-American men undergoing radical retropubic prostatectomy during the prostate specific antigen era - Implications for screening a high-risk group for prostate carcinoma
Authors: Paquette, EL Connelly, RR Sesterhenn, IA Zhang, W Sun, L Paquette, LR Greenspan, R McLeod, DG Moul, JW
Citation: El. Paquette et al., Improvements in pathologic staging for African-American men undergoing radical retropubic prostatectomy during the prostate specific antigen era - Implications for screening a high-risk group for prostate carcinoma, CANCER, 92(10), 2001, pp. 2673-2679
Laser-capture microdissection
Authors: Griewe, GL Dean, R Zhang, W Sesterhenn, IA Srivastava, S Moul, JW
Citation: Gl. Griewe et al., Laser-capture microdissection, METH MOL M, 53, 2001, pp. 165-173
Artificial neural networks in urologic oncology
Authors: Douglas, TH Moul, JW
Citation: Th. Douglas et Jw. Moul, Artificial neural networks in urologic oncology, BIOMED EN S, 2001, pp. 93-101
Targeted screening for prostate cancer in African-American men
Authors: Moul, JW
Citation: Jw. Moul, Targeted screening for prostate cancer in African-American men, PROSTATE C, 3(4), 2000, pp. 248-255
The role of pretreatment serum albumin to predict pathological stage and recurrence among radical prostatectomy cases
Authors: Richter, E Connelly, RR Moul, JW
Citation: E. Richter et al., The role of pretreatment serum albumin to predict pathological stage and recurrence among radical prostatectomy cases, PROSTATE C, 3(3), 2000, pp. 186-190
Lateral biopsies added to the traditional sextant prostate biopsy pattern increases the detection rate of prostate cancer
Authors: Bauer, JJ Zeng, J Zhang, W McLeod, DG Sesterhenn, IA Connelly, RR Mun, SK Moul, JW
Citation: Jj. Bauer et al., Lateral biopsies added to the traditional sextant prostate biopsy pattern increases the detection rate of prostate cancer, PROSTATE C, 3(1), 2000, pp. 43-46
Hormonal therapy options for biochemical recurrence of prostate cancer after local therapy
Authors: Moul, JW
Citation: Jw. Moul, Hormonal therapy options for biochemical recurrence of prostate cancer after local therapy, MOL UROL, 4(3), 2000, pp. 267-271
Hormonal therapy options for biochemical recurrence of prostate cancer after local therapy - Open discussion following Dr. Moul's presentation
Authors: Thrasher, B Moul, JW Debruyne, F Sylvester, J Fair, W Grignon, D
Citation: B. Thrasher et al., Hormonal therapy options for biochemical recurrence of prostate cancer after local therapy - Open discussion following Dr. Moul's presentation, MOL UROL, 4(3), 2000, pp. 273-273
A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate (vol 66, pg 257, 2000)
Authors: Xu, LL Shanmugam, N Segawa, T Sesterhenn, IA McLeod, DG Moul, JW Srivastava, S
Citation: Ll. Xu et al., A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate (vol 66, pg 257, 2000), GENOMICS, 70(3), 2000, pp. 407-407
A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate
Authors: Xu, LL Shanmugam, N Segawa, T Sesterhenn, IA McLeod, DG Moul, JW Srivastava, S
Citation: Ll. Xu et al., A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate, GENOMICS, 66(3), 2000, pp. 257-263
Aneuploidy of chromosome 9 and the tumor suppressor genes p16(INK4) and p15(INK4B) detected by in situ hybridization in locally advanced prostate cancer
Authors: Heidenreich, B Heidenreich, A Sesterhenn, A Srivastava, S Moul, JW Sesterhenn, IA
Citation: B. Heidenreich et al., Aneuploidy of chromosome 9 and the tumor suppressor genes p16(INK4) and p15(INK4B) detected by in situ hybridization in locally advanced prostate cancer, EUR UROL, 38(4), 2000, pp. 475-482
Risultati: 1-25 | 26-50 | 51-57